Home › Funds › Drexel Morgan & Co. › NVS
Drexel Morgan & Co. position in NVS
NOVARTIS AG · Health Care
Drexel Morgan & Co. reported holding 10,720 shares of NVS (NOVARTIS AG) in its Q3 2026 13F filing — a position valued at US$1.5M, representing 0.20% of its reported portfolio and ranking #38 among its reported holdings. Drexel Morgan & Co. has disclosed NVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Drexel Morgan & Co.'s NVS position evolved
Drexel Morgan & Co. first disclosed a stake in NVS in Q3 2023 at 9,720 shares (US$990K). The position peaked in Q2 2026 at 10,720 shares, worth US$1.7M. Across 13 filings, Drexel Morgan & Co. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 10,720 shares valued at US$1.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 9.72K | $990.08K | New |
| Q4 2023 | 9.72K | $981.43K | Hold |
| Q1 2024 | 9.72K | $940.22K | Hold |
| Q2 2024 | 9.72K | $1.03M | Hold |
| Q3 2024 | 9.72K | $1.12M | Hold |
| Q4 2024 | 9.72K | $945.85K | Hold |
| Q1 2025 | 9.72K | $1.08M | Hold |
| Q2 2025 | 10.72K | $1.30M | Add |
| Q3 2025 | 10.72K | $1.37M | Hold |
| Q4 2025 | 10.72K | $1.48M | Hold |
| Q1 2026 | 10.72K | $1.64M | Hold |
| Q2 2026 | 10.72K | $1.68M | Hold |
| Q3 2026 | 10.72K | $1.53M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NVS and 13F data
NVS (NOVARTIS AG) is a Health Care company. 20 other funds we track also report a position in NVS — the largest reported positions include Fisher Asset Management, LLC (US$2.39B), PRIMECAP MANAGEMENT CO/CA/ (US$938.9M), LOOMIS SAYLES & CO L P (US$689.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NVS
- Fisher Asset Management, LLC 16.76M sh · $2.39B · Q3 2026
- PRIMECAP MANAGEMENT CO/CA/ 6.59M sh · $938.89M · Q3 2026
- LOOMIS SAYLES & CO L P 4.83M sh · $689.20M · Q3 2026
- Cullen Capital Management, LLC 1.95M sh · $278.55M · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 1.72M sh · $250.18M · Q3 2026
More on Drexel Morgan & Co.
FAQ
How long has Drexel Morgan & Co. held NVS?
Drexel Morgan & Co. has disclosed NVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Drexel Morgan & Co.'s current position in NVS?
As of Q3 2026, Drexel Morgan & Co. holds 10.72K shares of NVS (NOVARTIS AG), valued at $1.53M, representing 0.20% of its reported portfolio and ranking #38.
Has Drexel Morgan & Co. been buying or selling NVS?
In the latest 13F filing (Q3 2026), Drexel Morgan & Co. held unchanged its position in NVS. The position peaked in Q2 2026 at 10.72K shares.
Which other funds hold NVS?
Other major institutional holders of NVS include Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, LOOMIS SAYLES & CO L P, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.